A trial with a total of 24 European sea bass (mean weight 337±75 g) was conducted to investigate the biological effects of two vitamin C sources, ascorbyl 2-polyphosphate (AP) and ascorbyl 2-sulfate (AS). The fish were held in fiberglass tanks at a density of four fish per tank in synthetic seawater with 17‰ salinity, a temperature of 20°C and 8.2–11.2 mg l −1 dissolved oxygen. The sea bass were fed a vitamin C-free diet for 20 days before and 21 days after oral administration of the two sources of vitamin C as pills (2 pills, each containing 10 mg vitamin C). The placebo and two sources of vitamin C were assigned randomly to the tanks and administered by force feeding. To determine plasma ascorbic acid levels, a pre-experimental blood sample was taken 48 h before oral administration, then 5 h after forced feeding the vitamin C sources and on day 1, 2, 6, 8, 14 and 21 of the post-application period. At 48 h before forced feeding, a plasma l-ascorbic acid value of 3.1 mg l −1 was found. The highest concentration of plasma l-ascorbic acid for both sources of vitamin C was observed 5 h after force feeding (AP 20.7 mg l −1, AS 8.3 mg l −1). On day 1, the level of plasma l-ascorbic acid started to decrease until the end of the experiment at day 21. The average plasma l-ascorbic acid level of fish fed AP was significantly higher than the value of fish fed ascorbyl 2-sulfate and the placebo. These results indicate that l-ascorbic acid is more rapidly adsorbed when administered as ascorbyl 2-polyphosphate and has a higher bioavailability than ascorbyl 2-sulfate in European sea bass.
Read full abstract